![]() |
市場調查報告書
商品編碼
1497796
美容注射市場:按產品、性別、應用和最終用戶 - 2024-2030 年全球預測Aesthetic Injectables Market by Product (Anti-aging Injections, Dermal Fillers), Gender (Female, Male), Application, End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年注射美容市場規模為110.8億美元,預計2024年將達119.5億美元,2030年將達188.1億美元,複合年成長率為7.85%。
美容注射是非手術美容治療,將肉毒桿菌毒素或皮膚填充劑等物質注射到皮膚中,以減少皺紋的出現,增強臉部輪廓,並恢復失去的體積。這些手術旨在提供更年輕的外觀,無需進行侵入性手術,最大限度地減少停機時間,並提供更快、更少痛苦的替代方案。由於社群媒體和名人的影響,社會越來越重視外表和年輕,這推動了美容注射的需求。人們越來越注重自己的外表,並尋求治療來保持年輕的外表。微創技術的進步使這些手術更安全、更有效、副作用更少、恢復時間更快。可支配收入的增加使更多人能夠獲得這些治療,進一步推動了市場的擴張。使用美容注射可能會導致副作用和併發症,包括瘀傷和腫脹,從而阻礙市場成長。這些風險可能會阻止潛在客戶。注射劑配方和技術的持續創新預計將透過提高治療的功效和安全性以及改善結果並減少副作用來創造市場成長機會。
主要市場統計 | |
---|---|
基準年[2023] | 110.8億美元 |
預測年份 [2024] | 119.5億美元 |
預測年份 [2030] | 188.1億美元 |
複合年成長率(%) | 7.85% |
區域洞察
由於高可支配收入、重視外表的趨勢以及整容手術的廣泛接受,以北美為中心的北美和南美注射美容市場保持強勁並持續成長。大量美容醫生的存在、注射技術的不斷進步以及強勁的消費者需求正在推動美洲市場的成長。由於人們對美容療程的認知和接受度不斷提高,南美洲正在呈現持續成長。由於可支配收入的增加、都市化以及對美容和個人護理有著濃厚興趣的中階的不斷壯大,亞太地區(APAC)的美容注射市場正在迅速擴張。韓國、日本和中國等國家處於領先地位,其中韓國尤其被譽為先進的整容手術和非手術手術市場。重視年輕的文化以及社群媒體和名流文化的影響力是主要驅動力。此外,與西方國家相比,治療成本相對較低,使得這些治療更容易獲得。歐洲、中東和非洲 (EMEA) 地區是美容注射的多元化市場。在高可支配收入、強大的醫療保健系統和廣泛的社會接受度的推動下,英國、德國和法國等國家對非手術整容手術的需求很高,處於領先地位。中東潛力大,尤其是阿拉伯聯合大公國和沙烏地阿拉伯,富人眾多,對奢侈品和美容服務的需求旺盛。非洲仍然是一個新興市場,市場成長主要集中在都市區,這些地區經濟狀況不斷改善,美容意識不斷增強。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在美容注射劑市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對美容注射市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在美容注射劑市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[187 Pages Report] The Aesthetic Injectables Market size was estimated at USD 11.08 billion in 2023 and expected to reach USD 11.95 billion in 2024, at a CAGR 7.85% to reach USD 18.81 billion by 2030.
Aesthetic injectables are non-surgical cosmetic treatments that involve injecting substances such as botulinum toxin and dermal fillers into the skin to decrease the appearance of wrinkles, enhance facial contours, and restore lost volume. These procedures are designed to provide a youthful appearance without the need for invasive surgery, offering a quicker, less painful alternative with minimal downtime. The heightened societal emphasis on physical appearance and youthfulness fueled by social media and the influence of celebrities is driving the demand for aesthetic injectables. People are more conscious of their looks and seek treatments that help them maintain a youthful appearance. Advancements in minimally invasive techniques have made these procedures safer and more effective, with fewer side effects and shorter recovery times. Rising disposable incomes, which have enabled more people to afford these treatments are boarding the scope of the market. The potential for side effects and complications, which can include bruising and swelling, with the use of aesthetic injectables hampers the market's growth. These risks can deter potential clients. Continuous innovation in injectable formulations and techniques enhances the efficacy and safety of treatments potentially reducing the side effects, and improving results are expected to create opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 11.08 billion |
Estimated Year [2024] | USD 11.95 billion |
Forecast Year [2030] | USD 18.81 billion |
CAGR (%) | 7.85% |
Regional Insights
The market for aesthetic injectables in the Americas, particularly North America, is robust and continues to grow due to high disposable incomes, a strong emphasis on physical appearance, and widespread acceptance of cosmetic procedures. The presence of a large number of aesthetic practitioners, continuous advancements in injectable technologies, and significant consumer demand drive the market growth in the Americas. South America is representing continuous growth, spurred by increasing awareness and acceptance of aesthetic treatments. In the Asia-Pacific (APAC) region, the aesthetic injectables market is expanding rapidly, fueled by rising disposable incomes, urbanization, and a growing middle class with a strong interest in beauty and personal care. Countries such as South Korea, Japan, and China are at the forefront, with South Korea particularly known for its advanced cosmetic surgery and non-surgical procedure market. The cultural emphasis on youthful appearances and the influence of social media and celebrity culture are significant drivers. Additionally, the relatively lower procedure cost than in Western countries makes these treatments more accessible. The Europe, Middle East, and Africa (EMEA) region presents a diverse market for aesthetic injectables. Countries such as the United Kingdom, Germany, and France lead with high demand for non-surgical cosmetic procedures, driven by high disposable incomes, strong healthcare systems, and widespread societal acceptance. The Middle East shows significant potential, particularly in affluent countries including the UAE and Saudi Arabia, with a strong demand for luxury and beauty services. In Africa, the market is still emerging, with growth primarily in urban centers where economic conditions are improving and awareness of aesthetic procedures is increasing.
Market Insights
The market dynamics represent an ever-changing landscape of the Aesthetic Injectables Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Aesthetic Injectables Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Aesthetic Injectables Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Cynosure and Lutronic Merge to Form Global Leader in Medical Aesthetic Technology
Cynosure and Hahn & Company, the recent acquirer of Lutronic, have announced their definitive agreement to merge Cynosure and Lutronic. Both companies are prominent energy-based medical aesthetic systems providers, and this merger creates a leading global medical aesthetics technology company. The combined entity features a diverse and innovative product portfolio, operational in over 130 countries. [Published On: 2024-01-20]
Galderma Launches FACE by Galderma, a New AR Tool Helps Visualize Injectable Treatment Results
Galderma has introduced FACE by Galderma, an augmented reality (AR) tool designed for aesthetic professionals and patients to visualize injectable treatment results before the procedure begins. This tool provides a simulated real-time "before and after" visual, helping to address patient concerns about the outcomes of injectable treatment. [Published On: 2023-03-22]
FDA Approves SKINVIVE by JUVEDERM, a new U.S. Hyaluronic Acid Injection for Smoother Cheeks
Allergan Aesthetics, an AbbVie company, has announced the U.S. FDA approval of SKINVIVE by JUVEDERM for enhancing skin smoothness in adults over 21. This product is the first and only hyaluronic acid (HA) intradermal microdroplet injection in the U.S., designed to improve skin quality in the cheeks. The injectable contains a small amount of lidocaine and provides hydration and smoothness, with results lasting up to six months and optimal treatment. [Published On: 2023-03-15]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Aesthetic Injectables Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Aesthetic Injectables Market, highlighting leading vendors and their innovative profiles. These include Adoderm GmbH, Allergan, Inc. by AbbVie Inc., Anika Therapeutics, Inc., Bio Plus Co., Ltd., Bioxis Pharmaceuticals, Bloomage Biotechnology Corp., Ltd., Bohus Biotech AB, Croma-Pharma GmbH, Cutera, Inc., Cynosure, LLC, Dr. Korman Laboratories Ltd., Galderma SA, Hugel America, Inc., Ipsen Pharma, Laboratoires Vivacy, S.A.S., MedyTox Inc., Merz Pharma GmbH & Co.KGaA, Prollenium Medical Technologies Inc., Revance Therapeutics, Inc., SciVision Biotech Inc., Sinclair Pharma Ltd, Suneva Medical, Inc., Teoxane SA, USWM, LLC, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
T